Medical Care
Global Cancer Stem Cells Market Research Report 2025
- Sep 09, 25
- ID: 494623
- Pages: 87
- Figures: 86
- Views: 21
This report aims to provide a comprehensive presentation of the global market for Cancer Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Stem Cells.
The Cancer Stem Cells market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Stem Cells companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Abbvie
Merck Kgaa
Bionomics
Lonza
Stemline Therapeutics
Miltenyi Biotec
Promocell
Macrogenics
Oncomed Pharmaceuticals
Irvine Scientific
Stemcell Technologies
Sino Biological
Biotime
Segment by Type
Cell Culturing
Cell Separation
Cell Analysis
Molecular Analysis
Others
Segment by Application
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Stem Cells company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Cancer Stem Cells market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Stem Cells companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Abbvie
Merck Kgaa
Bionomics
Lonza
Stemline Therapeutics
Miltenyi Biotec
Promocell
Macrogenics
Oncomed Pharmaceuticals
Irvine Scientific
Stemcell Technologies
Sino Biological
Biotime
Segment by Type
Cell Culturing
Cell Separation
Cell Analysis
Molecular Analysis
Others
Segment by Application
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Stem Cells company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Stem Cells Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cell Culturing
1.2.3 Cell Separation
1.2.4 Cell Analysis
1.2.5 Molecular Analysis
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cancer Stem Cells Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer Diagnosis and Treatment
1.3.3 Prostate Cancer Diagnosis and Treatment
1.3.4 Colorectal Cancer Diagnosis and Treatment
1.3.5 Lung Cancer Diagnosis and Treatment
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Stem Cells Market Perspective (2020-2031)
2.2 Global Cancer Stem Cells Growth Trends by Region
2.2.1 Global Cancer Stem Cells Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Stem Cells Historic Market Size by Region (2020-2025)
2.2.3 Cancer Stem Cells Forecasted Market Size by Region (2026-2031)
2.3 Cancer Stem Cells Market Dynamics
2.3.1 Cancer Stem Cells Industry Trends
2.3.2 Cancer Stem Cells Market Drivers
2.3.3 Cancer Stem Cells Market Challenges
2.3.4 Cancer Stem Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Stem Cells Players by Revenue
3.1.1 Global Top Cancer Stem Cells Players by Revenue (2020-2025)
3.1.2 Global Cancer Stem Cells Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Stem Cells Revenue
3.4 Global Cancer Stem Cells Market Concentration Ratio
3.4.1 Global Cancer Stem Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Stem Cells Revenue in 2024
3.5 Global Key Players of Cancer Stem Cells Head office and Area Served
3.6 Global Key Players of Cancer Stem Cells, Product and Application
3.7 Global Key Players of Cancer Stem Cells, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Stem Cells Breakdown Data by Type
4.1 Global Cancer Stem Cells Historic Market Size by Type (2020-2025)
4.2 Global Cancer Stem Cells Forecasted Market Size by Type (2026-2031)
5 Cancer Stem Cells Breakdown Data by Application
5.1 Global Cancer Stem Cells Historic Market Size by Application (2020-2025)
5.2 Global Cancer Stem Cells Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Stem Cells Market Size (2020-2031)
6.2 North America Cancer Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Stem Cells Market Size by Country (2020-2025)
6.4 North America Cancer Stem Cells Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Stem Cells Market Size (2020-2031)
7.2 Europe Cancer Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Stem Cells Market Size by Country (2020-2025)
7.4 Europe Cancer Stem Cells Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Stem Cells Market Size (2020-2031)
8.2 Asia-Pacific Cancer Stem Cells Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Stem Cells Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Stem Cells Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Stem Cells Market Size (2020-2031)
9.2 Latin America Cancer Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Stem Cells Market Size by Country (2020-2025)
9.4 Latin America Cancer Stem Cells Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Stem Cells Market Size (2020-2031)
10.2 Middle East & Africa Cancer Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Stem Cells Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Stem Cells Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cancer Stem Cells Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cancer Stem Cells Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Abbvie
11.2.1 Abbvie Company Details
11.2.2 Abbvie Business Overview
11.2.3 Abbvie Cancer Stem Cells Introduction
11.2.4 Abbvie Revenue in Cancer Stem Cells Business (2020-2025)
11.2.5 Abbvie Recent Development
11.3 Merck Kgaa
11.3.1 Merck Kgaa Company Details
11.3.2 Merck Kgaa Business Overview
11.3.3 Merck Kgaa Cancer Stem Cells Introduction
11.3.4 Merck Kgaa Revenue in Cancer Stem Cells Business (2020-2025)
11.3.5 Merck Kgaa Recent Development
11.4 Bionomics
11.4.1 Bionomics Company Details
11.4.2 Bionomics Business Overview
11.4.3 Bionomics Cancer Stem Cells Introduction
11.4.4 Bionomics Revenue in Cancer Stem Cells Business (2020-2025)
11.4.5 Bionomics Recent Development
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza Cancer Stem Cells Introduction
11.5.4 Lonza Revenue in Cancer Stem Cells Business (2020-2025)
11.5.5 Lonza Recent Development
11.6 Stemline Therapeutics
11.6.1 Stemline Therapeutics Company Details
11.6.2 Stemline Therapeutics Business Overview
11.6.3 Stemline Therapeutics Cancer Stem Cells Introduction
11.6.4 Stemline Therapeutics Revenue in Cancer Stem Cells Business (2020-2025)
11.6.5 Stemline Therapeutics Recent Development
11.7 Miltenyi Biotec
11.7.1 Miltenyi Biotec Company Details
11.7.2 Miltenyi Biotec Business Overview
11.7.3 Miltenyi Biotec Cancer Stem Cells Introduction
11.7.4 Miltenyi Biotec Revenue in Cancer Stem Cells Business (2020-2025)
11.7.5 Miltenyi Biotec Recent Development
11.8 Promocell
11.8.1 Promocell Company Details
11.8.2 Promocell Business Overview
11.8.3 Promocell Cancer Stem Cells Introduction
11.8.4 Promocell Revenue in Cancer Stem Cells Business (2020-2025)
11.8.5 Promocell Recent Development
11.9 Macrogenics
11.9.1 Macrogenics Company Details
11.9.2 Macrogenics Business Overview
11.9.3 Macrogenics Cancer Stem Cells Introduction
11.9.4 Macrogenics Revenue in Cancer Stem Cells Business (2020-2025)
11.9.5 Macrogenics Recent Development
11.10 Oncomed Pharmaceuticals
11.10.1 Oncomed Pharmaceuticals Company Details
11.10.2 Oncomed Pharmaceuticals Business Overview
11.10.3 Oncomed Pharmaceuticals Cancer Stem Cells Introduction
11.10.4 Oncomed Pharmaceuticals Revenue in Cancer Stem Cells Business (2020-2025)
11.10.5 Oncomed Pharmaceuticals Recent Development
11.11 Irvine Scientific
11.11.1 Irvine Scientific Company Details
11.11.2 Irvine Scientific Business Overview
11.11.3 Irvine Scientific Cancer Stem Cells Introduction
11.11.4 Irvine Scientific Revenue in Cancer Stem Cells Business (2020-2025)
11.11.5 Irvine Scientific Recent Development
11.12 Stemcell Technologies
11.12.1 Stemcell Technologies Company Details
11.12.2 Stemcell Technologies Business Overview
11.12.3 Stemcell Technologies Cancer Stem Cells Introduction
11.12.4 Stemcell Technologies Revenue in Cancer Stem Cells Business (2020-2025)
11.12.5 Stemcell Technologies Recent Development
11.13 Sino Biological
11.13.1 Sino Biological Company Details
11.13.2 Sino Biological Business Overview
11.13.3 Sino Biological Cancer Stem Cells Introduction
11.13.4 Sino Biological Revenue in Cancer Stem Cells Business (2020-2025)
11.13.5 Sino Biological Recent Development
11.14 Biotime
11.14.1 Biotime Company Details
11.14.2 Biotime Business Overview
11.14.3 Biotime Cancer Stem Cells Introduction
11.14.4 Biotime Revenue in Cancer Stem Cells Business (2020-2025)
11.14.5 Biotime Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Stem Cells Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cell Culturing
1.2.3 Cell Separation
1.2.4 Cell Analysis
1.2.5 Molecular Analysis
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cancer Stem Cells Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer Diagnosis and Treatment
1.3.3 Prostate Cancer Diagnosis and Treatment
1.3.4 Colorectal Cancer Diagnosis and Treatment
1.3.5 Lung Cancer Diagnosis and Treatment
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Stem Cells Market Perspective (2020-2031)
2.2 Global Cancer Stem Cells Growth Trends by Region
2.2.1 Global Cancer Stem Cells Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Stem Cells Historic Market Size by Region (2020-2025)
2.2.3 Cancer Stem Cells Forecasted Market Size by Region (2026-2031)
2.3 Cancer Stem Cells Market Dynamics
2.3.1 Cancer Stem Cells Industry Trends
2.3.2 Cancer Stem Cells Market Drivers
2.3.3 Cancer Stem Cells Market Challenges
2.3.4 Cancer Stem Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Stem Cells Players by Revenue
3.1.1 Global Top Cancer Stem Cells Players by Revenue (2020-2025)
3.1.2 Global Cancer Stem Cells Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Stem Cells Revenue
3.4 Global Cancer Stem Cells Market Concentration Ratio
3.4.1 Global Cancer Stem Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Stem Cells Revenue in 2024
3.5 Global Key Players of Cancer Stem Cells Head office and Area Served
3.6 Global Key Players of Cancer Stem Cells, Product and Application
3.7 Global Key Players of Cancer Stem Cells, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Stem Cells Breakdown Data by Type
4.1 Global Cancer Stem Cells Historic Market Size by Type (2020-2025)
4.2 Global Cancer Stem Cells Forecasted Market Size by Type (2026-2031)
5 Cancer Stem Cells Breakdown Data by Application
5.1 Global Cancer Stem Cells Historic Market Size by Application (2020-2025)
5.2 Global Cancer Stem Cells Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Stem Cells Market Size (2020-2031)
6.2 North America Cancer Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Stem Cells Market Size by Country (2020-2025)
6.4 North America Cancer Stem Cells Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Stem Cells Market Size (2020-2031)
7.2 Europe Cancer Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Stem Cells Market Size by Country (2020-2025)
7.4 Europe Cancer Stem Cells Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Stem Cells Market Size (2020-2031)
8.2 Asia-Pacific Cancer Stem Cells Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Stem Cells Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Stem Cells Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Stem Cells Market Size (2020-2031)
9.2 Latin America Cancer Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Stem Cells Market Size by Country (2020-2025)
9.4 Latin America Cancer Stem Cells Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Stem Cells Market Size (2020-2031)
10.2 Middle East & Africa Cancer Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Stem Cells Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Stem Cells Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cancer Stem Cells Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cancer Stem Cells Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Abbvie
11.2.1 Abbvie Company Details
11.2.2 Abbvie Business Overview
11.2.3 Abbvie Cancer Stem Cells Introduction
11.2.4 Abbvie Revenue in Cancer Stem Cells Business (2020-2025)
11.2.5 Abbvie Recent Development
11.3 Merck Kgaa
11.3.1 Merck Kgaa Company Details
11.3.2 Merck Kgaa Business Overview
11.3.3 Merck Kgaa Cancer Stem Cells Introduction
11.3.4 Merck Kgaa Revenue in Cancer Stem Cells Business (2020-2025)
11.3.5 Merck Kgaa Recent Development
11.4 Bionomics
11.4.1 Bionomics Company Details
11.4.2 Bionomics Business Overview
11.4.3 Bionomics Cancer Stem Cells Introduction
11.4.4 Bionomics Revenue in Cancer Stem Cells Business (2020-2025)
11.4.5 Bionomics Recent Development
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza Cancer Stem Cells Introduction
11.5.4 Lonza Revenue in Cancer Stem Cells Business (2020-2025)
11.5.5 Lonza Recent Development
11.6 Stemline Therapeutics
11.6.1 Stemline Therapeutics Company Details
11.6.2 Stemline Therapeutics Business Overview
11.6.3 Stemline Therapeutics Cancer Stem Cells Introduction
11.6.4 Stemline Therapeutics Revenue in Cancer Stem Cells Business (2020-2025)
11.6.5 Stemline Therapeutics Recent Development
11.7 Miltenyi Biotec
11.7.1 Miltenyi Biotec Company Details
11.7.2 Miltenyi Biotec Business Overview
11.7.3 Miltenyi Biotec Cancer Stem Cells Introduction
11.7.4 Miltenyi Biotec Revenue in Cancer Stem Cells Business (2020-2025)
11.7.5 Miltenyi Biotec Recent Development
11.8 Promocell
11.8.1 Promocell Company Details
11.8.2 Promocell Business Overview
11.8.3 Promocell Cancer Stem Cells Introduction
11.8.4 Promocell Revenue in Cancer Stem Cells Business (2020-2025)
11.8.5 Promocell Recent Development
11.9 Macrogenics
11.9.1 Macrogenics Company Details
11.9.2 Macrogenics Business Overview
11.9.3 Macrogenics Cancer Stem Cells Introduction
11.9.4 Macrogenics Revenue in Cancer Stem Cells Business (2020-2025)
11.9.5 Macrogenics Recent Development
11.10 Oncomed Pharmaceuticals
11.10.1 Oncomed Pharmaceuticals Company Details
11.10.2 Oncomed Pharmaceuticals Business Overview
11.10.3 Oncomed Pharmaceuticals Cancer Stem Cells Introduction
11.10.4 Oncomed Pharmaceuticals Revenue in Cancer Stem Cells Business (2020-2025)
11.10.5 Oncomed Pharmaceuticals Recent Development
11.11 Irvine Scientific
11.11.1 Irvine Scientific Company Details
11.11.2 Irvine Scientific Business Overview
11.11.3 Irvine Scientific Cancer Stem Cells Introduction
11.11.4 Irvine Scientific Revenue in Cancer Stem Cells Business (2020-2025)
11.11.5 Irvine Scientific Recent Development
11.12 Stemcell Technologies
11.12.1 Stemcell Technologies Company Details
11.12.2 Stemcell Technologies Business Overview
11.12.3 Stemcell Technologies Cancer Stem Cells Introduction
11.12.4 Stemcell Technologies Revenue in Cancer Stem Cells Business (2020-2025)
11.12.5 Stemcell Technologies Recent Development
11.13 Sino Biological
11.13.1 Sino Biological Company Details
11.13.2 Sino Biological Business Overview
11.13.3 Sino Biological Cancer Stem Cells Introduction
11.13.4 Sino Biological Revenue in Cancer Stem Cells Business (2020-2025)
11.13.5 Sino Biological Recent Development
11.14 Biotime
11.14.1 Biotime Company Details
11.14.2 Biotime Business Overview
11.14.3 Biotime Cancer Stem Cells Introduction
11.14.4 Biotime Revenue in Cancer Stem Cells Business (2020-2025)
11.14.5 Biotime Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cancer Stem Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cell Culturing
Table 3. Key Players of Cell Separation
Table 4. Key Players of Cell Analysis
Table 5. Key Players of Molecular Analysis
Table 6. Key Players of Others
Table 7. Global Cancer Stem Cells Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Cancer Stem Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Cancer Stem Cells Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Cancer Stem Cells Market Share by Region (2020-2025)
Table 11. Global Cancer Stem Cells Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Cancer Stem Cells Market Share by Region (2026-2031)
Table 13. Cancer Stem Cells Market Trends
Table 14. Cancer Stem Cells Market Drivers
Table 15. Cancer Stem Cells Market Challenges
Table 16. Cancer Stem Cells Market Restraints
Table 17. Global Cancer Stem Cells Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Cancer Stem Cells Market Share by Players (2020-2025)
Table 19. Global Top Cancer Stem Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Stem Cells as of 2024)
Table 20. Ranking of Global Top Cancer Stem Cells Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Cancer Stem Cells Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Cancer Stem Cells, Headquarters and Area Served
Table 23. Global Key Players of Cancer Stem Cells, Product and Application
Table 24. Global Key Players of Cancer Stem Cells, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cancer Stem Cells Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Cancer Stem Cells Revenue Market Share by Type (2020-2025)
Table 28. Global Cancer Stem Cells Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Cancer Stem Cells Revenue Market Share by Type (2026-2031)
Table 30. Global Cancer Stem Cells Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Cancer Stem Cells Revenue Market Share by Application (2020-2025)
Table 32. Global Cancer Stem Cells Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Cancer Stem Cells Revenue Market Share by Application (2026-2031)
Table 34. North America Cancer Stem Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Cancer Stem Cells Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Cancer Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Cancer Stem Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Cancer Stem Cells Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Cancer Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Cancer Stem Cells Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Cancer Stem Cells Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Cancer Stem Cells Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Cancer Stem Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Cancer Stem Cells Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Cancer Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Cancer Stem Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Cancer Stem Cells Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Cancer Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 49. Thermo Fisher Scientific Company Details
Table 50. Thermo Fisher Scientific Business Overview
Table 51. Thermo Fisher Scientific Cancer Stem Cells Product
Table 52. Thermo Fisher Scientific Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 53. Thermo Fisher Scientific Recent Development
Table 54. Abbvie Company Details
Table 55. Abbvie Business Overview
Table 56. Abbvie Cancer Stem Cells Product
Table 57. Abbvie Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 58. Abbvie Recent Development
Table 59. Merck Kgaa Company Details
Table 60. Merck Kgaa Business Overview
Table 61. Merck Kgaa Cancer Stem Cells Product
Table 62. Merck Kgaa Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 63. Merck Kgaa Recent Development
Table 64. Bionomics Company Details
Table 65. Bionomics Business Overview
Table 66. Bionomics Cancer Stem Cells Product
Table 67. Bionomics Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 68. Bionomics Recent Development
Table 69. Lonza Company Details
Table 70. Lonza Business Overview
Table 71. Lonza Cancer Stem Cells Product
Table 72. Lonza Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 73. Lonza Recent Development
Table 74. Stemline Therapeutics Company Details
Table 75. Stemline Therapeutics Business Overview
Table 76. Stemline Therapeutics Cancer Stem Cells Product
Table 77. Stemline Therapeutics Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 78. Stemline Therapeutics Recent Development
Table 79. Miltenyi Biotec Company Details
Table 80. Miltenyi Biotec Business Overview
Table 81. Miltenyi Biotec Cancer Stem Cells Product
Table 82. Miltenyi Biotec Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 83. Miltenyi Biotec Recent Development
Table 84. Promocell Company Details
Table 85. Promocell Business Overview
Table 86. Promocell Cancer Stem Cells Product
Table 87. Promocell Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 88. Promocell Recent Development
Table 89. Macrogenics Company Details
Table 90. Macrogenics Business Overview
Table 91. Macrogenics Cancer Stem Cells Product
Table 92. Macrogenics Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 93. Macrogenics Recent Development
Table 94. Oncomed Pharmaceuticals Company Details
Table 95. Oncomed Pharmaceuticals Business Overview
Table 96. Oncomed Pharmaceuticals Cancer Stem Cells Product
Table 97. Oncomed Pharmaceuticals Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 98. Oncomed Pharmaceuticals Recent Development
Table 99. Irvine Scientific Company Details
Table 100. Irvine Scientific Business Overview
Table 101. Irvine Scientific Cancer Stem Cells Product
Table 102. Irvine Scientific Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 103. Irvine Scientific Recent Development
Table 104. Stemcell Technologies Company Details
Table 105. Stemcell Technologies Business Overview
Table 106. Stemcell Technologies Cancer Stem Cells Product
Table 107. Stemcell Technologies Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 108. Stemcell Technologies Recent Development
Table 109. Sino Biological Company Details
Table 110. Sino Biological Business Overview
Table 111. Sino Biological Cancer Stem Cells Product
Table 112. Sino Biological Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 113. Sino Biological Recent Development
Table 114. Biotime Company Details
Table 115. Biotime Business Overview
Table 116. Biotime Cancer Stem Cells Product
Table 117. Biotime Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 118. Biotime Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 122. Authors List of This Report
List of Figures
Figure 1. Cancer Stem Cells Picture
Figure 2. Global Cancer Stem Cells Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Stem Cells Market Share by Type: 2024 VS 2031
Figure 4. Cell Culturing Features
Figure 5. Cell Separation Features
Figure 6. Cell Analysis Features
Figure 7. Molecular Analysis Features
Figure 8. Others Features
Figure 9. Global Cancer Stem Cells Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Cancer Stem Cells Market Share by Application: 2024 VS 2031
Figure 11. Breast Cancer Diagnosis and Treatment Case Studies
Figure 12. Prostate Cancer Diagnosis and Treatment Case Studies
Figure 13. Colorectal Cancer Diagnosis and Treatment Case Studies
Figure 14. Lung Cancer Diagnosis and Treatment Case Studies
Figure 15. Others Case Studies
Figure 16. Cancer Stem Cells Report Years Considered
Figure 17. Global Cancer Stem Cells Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Cancer Stem Cells Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Cancer Stem Cells Market Share by Region: 2024 VS 2031
Figure 20. Global Cancer Stem Cells Market Share by Players in 2024
Figure 21. Global Top Cancer Stem Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Stem Cells as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Cancer Stem Cells Revenue in 2024
Figure 23. North America Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Cancer Stem Cells Market Share by Country (2020-2031)
Figure 25. United States Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Cancer Stem Cells Market Share by Country (2020-2031)
Figure 29. Germany Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Cancer Stem Cells Market Share by Region (2020-2031)
Figure 37. China Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Cancer Stem Cells Market Share by Country (2020-2031)
Figure 45. Mexico Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Cancer Stem Cells Market Share by Country (2020-2031)
Figure 49. Turkey Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 53. Abbvie Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 54. Merck Kgaa Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 55. Bionomics Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 56. Lonza Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 57. Stemline Therapeutics Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 58. Miltenyi Biotec Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 59. Promocell Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 60. Macrogenics Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 61. Oncomed Pharmaceuticals Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 62. Irvine Scientific Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 63. Stemcell Technologies Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 64. Sino Biological Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 65. Biotime Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global Cancer Stem Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cell Culturing
Table 3. Key Players of Cell Separation
Table 4. Key Players of Cell Analysis
Table 5. Key Players of Molecular Analysis
Table 6. Key Players of Others
Table 7. Global Cancer Stem Cells Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Cancer Stem Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Cancer Stem Cells Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Cancer Stem Cells Market Share by Region (2020-2025)
Table 11. Global Cancer Stem Cells Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Cancer Stem Cells Market Share by Region (2026-2031)
Table 13. Cancer Stem Cells Market Trends
Table 14. Cancer Stem Cells Market Drivers
Table 15. Cancer Stem Cells Market Challenges
Table 16. Cancer Stem Cells Market Restraints
Table 17. Global Cancer Stem Cells Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Cancer Stem Cells Market Share by Players (2020-2025)
Table 19. Global Top Cancer Stem Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Stem Cells as of 2024)
Table 20. Ranking of Global Top Cancer Stem Cells Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Cancer Stem Cells Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Cancer Stem Cells, Headquarters and Area Served
Table 23. Global Key Players of Cancer Stem Cells, Product and Application
Table 24. Global Key Players of Cancer Stem Cells, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cancer Stem Cells Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Cancer Stem Cells Revenue Market Share by Type (2020-2025)
Table 28. Global Cancer Stem Cells Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Cancer Stem Cells Revenue Market Share by Type (2026-2031)
Table 30. Global Cancer Stem Cells Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Cancer Stem Cells Revenue Market Share by Application (2020-2025)
Table 32. Global Cancer Stem Cells Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Cancer Stem Cells Revenue Market Share by Application (2026-2031)
Table 34. North America Cancer Stem Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Cancer Stem Cells Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Cancer Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Cancer Stem Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Cancer Stem Cells Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Cancer Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Cancer Stem Cells Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Cancer Stem Cells Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Cancer Stem Cells Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Cancer Stem Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Cancer Stem Cells Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Cancer Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Cancer Stem Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Cancer Stem Cells Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Cancer Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 49. Thermo Fisher Scientific Company Details
Table 50. Thermo Fisher Scientific Business Overview
Table 51. Thermo Fisher Scientific Cancer Stem Cells Product
Table 52. Thermo Fisher Scientific Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 53. Thermo Fisher Scientific Recent Development
Table 54. Abbvie Company Details
Table 55. Abbvie Business Overview
Table 56. Abbvie Cancer Stem Cells Product
Table 57. Abbvie Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 58. Abbvie Recent Development
Table 59. Merck Kgaa Company Details
Table 60. Merck Kgaa Business Overview
Table 61. Merck Kgaa Cancer Stem Cells Product
Table 62. Merck Kgaa Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 63. Merck Kgaa Recent Development
Table 64. Bionomics Company Details
Table 65. Bionomics Business Overview
Table 66. Bionomics Cancer Stem Cells Product
Table 67. Bionomics Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 68. Bionomics Recent Development
Table 69. Lonza Company Details
Table 70. Lonza Business Overview
Table 71. Lonza Cancer Stem Cells Product
Table 72. Lonza Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 73. Lonza Recent Development
Table 74. Stemline Therapeutics Company Details
Table 75. Stemline Therapeutics Business Overview
Table 76. Stemline Therapeutics Cancer Stem Cells Product
Table 77. Stemline Therapeutics Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 78. Stemline Therapeutics Recent Development
Table 79. Miltenyi Biotec Company Details
Table 80. Miltenyi Biotec Business Overview
Table 81. Miltenyi Biotec Cancer Stem Cells Product
Table 82. Miltenyi Biotec Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 83. Miltenyi Biotec Recent Development
Table 84. Promocell Company Details
Table 85. Promocell Business Overview
Table 86. Promocell Cancer Stem Cells Product
Table 87. Promocell Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 88. Promocell Recent Development
Table 89. Macrogenics Company Details
Table 90. Macrogenics Business Overview
Table 91. Macrogenics Cancer Stem Cells Product
Table 92. Macrogenics Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 93. Macrogenics Recent Development
Table 94. Oncomed Pharmaceuticals Company Details
Table 95. Oncomed Pharmaceuticals Business Overview
Table 96. Oncomed Pharmaceuticals Cancer Stem Cells Product
Table 97. Oncomed Pharmaceuticals Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 98. Oncomed Pharmaceuticals Recent Development
Table 99. Irvine Scientific Company Details
Table 100. Irvine Scientific Business Overview
Table 101. Irvine Scientific Cancer Stem Cells Product
Table 102. Irvine Scientific Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 103. Irvine Scientific Recent Development
Table 104. Stemcell Technologies Company Details
Table 105. Stemcell Technologies Business Overview
Table 106. Stemcell Technologies Cancer Stem Cells Product
Table 107. Stemcell Technologies Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 108. Stemcell Technologies Recent Development
Table 109. Sino Biological Company Details
Table 110. Sino Biological Business Overview
Table 111. Sino Biological Cancer Stem Cells Product
Table 112. Sino Biological Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 113. Sino Biological Recent Development
Table 114. Biotime Company Details
Table 115. Biotime Business Overview
Table 116. Biotime Cancer Stem Cells Product
Table 117. Biotime Revenue in Cancer Stem Cells Business (2020-2025) & (US$ Million)
Table 118. Biotime Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 122. Authors List of This Report
List of Figures
Figure 1. Cancer Stem Cells Picture
Figure 2. Global Cancer Stem Cells Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Stem Cells Market Share by Type: 2024 VS 2031
Figure 4. Cell Culturing Features
Figure 5. Cell Separation Features
Figure 6. Cell Analysis Features
Figure 7. Molecular Analysis Features
Figure 8. Others Features
Figure 9. Global Cancer Stem Cells Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Cancer Stem Cells Market Share by Application: 2024 VS 2031
Figure 11. Breast Cancer Diagnosis and Treatment Case Studies
Figure 12. Prostate Cancer Diagnosis and Treatment Case Studies
Figure 13. Colorectal Cancer Diagnosis and Treatment Case Studies
Figure 14. Lung Cancer Diagnosis and Treatment Case Studies
Figure 15. Others Case Studies
Figure 16. Cancer Stem Cells Report Years Considered
Figure 17. Global Cancer Stem Cells Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Cancer Stem Cells Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Cancer Stem Cells Market Share by Region: 2024 VS 2031
Figure 20. Global Cancer Stem Cells Market Share by Players in 2024
Figure 21. Global Top Cancer Stem Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Stem Cells as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Cancer Stem Cells Revenue in 2024
Figure 23. North America Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Cancer Stem Cells Market Share by Country (2020-2031)
Figure 25. United States Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Cancer Stem Cells Market Share by Country (2020-2031)
Figure 29. Germany Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Cancer Stem Cells Market Share by Region (2020-2031)
Figure 37. China Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Cancer Stem Cells Market Share by Country (2020-2031)
Figure 45. Mexico Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Cancer Stem Cells Market Share by Country (2020-2031)
Figure 49. Turkey Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 53. Abbvie Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 54. Merck Kgaa Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 55. Bionomics Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 56. Lonza Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 57. Stemline Therapeutics Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 58. Miltenyi Biotec Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 59. Promocell Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 60. Macrogenics Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 61. Oncomed Pharmaceuticals Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 62. Irvine Scientific Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 63. Stemcell Technologies Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 64. Sino Biological Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 65. Biotime Revenue Growth Rate in Cancer Stem Cells Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232